Dr. Tim Beukelman, Pediatric Rheumatology, has been awarded a New U34 NIH Cooperative Agreement, "The Effectiveness of Methotrexate to Prevent Extension of Early Limited JIA" in the amount of $356,864, for the period 9/1/14-8/31/2015.  6/2014

Stoll wins prestigious research award

Cron, Beukelman Chosen for ACR/EULAR International Academic Rheumatology Exchange  7/24/2012

Beukelman, colleagues probe the case of juvenile arthritis drug side effect  2/16/2012

Juvenile Idiopathic Arthritis May Raise Kids' Cancer Risk  2/13/2012

Arthritis Foundation's Jingle Bell Run honors two Birmingham-area teens  12/1/2010

Children with JIA face increase risk of developing cancer  11/17/2010

Pediatric Rheumatology Comes to Birmingham  9/3/2010

Specialists in juvenile arthritis start at Children's  9/3/2010